Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $18 at Morgan Stanley
Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $18.00 (from $21.00) while maintaining a Equalweight rating.